BRPI0719486A2 - "forma farmacêutica sólida oral desitegrante, não-efervescente, métodos para tratar uma mulher que necessite de um contraceptivo de emergência, pacote terapêutico para tratar uma mulher que necessite de contracepção de emergência e processo para a preparação de uma forma sólida de dosagem farmacêutica oral desintegrante, não-efervescente" - Google Patents
"forma farmacêutica sólida oral desitegrante, não-efervescente, métodos para tratar uma mulher que necessite de um contraceptivo de emergência, pacote terapêutico para tratar uma mulher que necessite de contracepção de emergência e processo para a preparação de uma forma sólida de dosagem farmacêutica oral desintegrante, não-efervescente"Info
- Publication number
- BRPI0719486A2 BRPI0719486A2 BRPI0719486-2A2A BRPI0719486A BRPI0719486A2 BR PI0719486 A2 BRPI0719486 A2 BR PI0719486A2 BR PI0719486 A BRPI0719486 A BR PI0719486A BR PI0719486 A2 BRPI0719486 A2 BR PI0719486A2
- Authority
- BR
- Brazil
- Prior art keywords
- treat
- woman
- preemphere
- desidgrant
- proparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US87582706P | 2006-12-20 | 2006-12-20 | |
PCT/US2007/025974 WO2008079245A2 (en) | 2006-12-20 | 2007-12-20 | Orally disintegrating solid dosage forms comprising progestin and methods of making and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0719486A2 true BRPI0719486A2 (pt) | 2014-02-18 |
Family
ID=39563076
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0719486-2A2A BRPI0719486A2 (pt) | 2006-12-20 | 2007-12-20 | "forma farmacêutica sólida oral desitegrante, não-efervescente, métodos para tratar uma mulher que necessite de um contraceptivo de emergência, pacote terapêutico para tratar uma mulher que necessite de contracepção de emergência e processo para a preparação de uma forma sólida de dosagem farmacêutica oral desintegrante, não-efervescente" |
Country Status (11)
Country | Link |
---|---|
US (2) | US7867515B2 (pt) |
EP (1) | EP2124900B1 (pt) |
JP (1) | JP5649305B2 (pt) |
AU (1) | AU2007338843B2 (pt) |
BR (1) | BRPI0719486A2 (pt) |
CA (1) | CA2674776A1 (pt) |
ES (1) | ES2531929T3 (pt) |
IL (1) | IL199472A0 (pt) |
MX (1) | MX2009006823A (pt) |
RU (1) | RU2465907C2 (pt) |
WO (1) | WO2008079245A2 (pt) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007095324A1 (en) * | 2006-02-14 | 2007-08-23 | The Procter & Gamble Company | Personal care compositions comprising responsive particles |
US7867515B2 (en) * | 2006-12-20 | 2011-01-11 | TEVA Woman's Health, Inc. | Orally disintegrating solid dosage forms comprising progestin and methods of making and use thereof |
BRPI0819571A2 (pt) * | 2007-12-20 | 2019-09-24 | Teva Womenss Health Inc | "método para contracepção de emergência, pacote farmacêutico para contracepção de emergência e composição farmacêutica" |
FR2937862B1 (fr) * | 2008-11-03 | 2010-11-19 | Mohammed Ridha Chakroun | Kit contraceptif |
US8512745B2 (en) | 2008-12-08 | 2013-08-20 | Laboratoire Hra Pharma | Ulipristal acetate tablets |
AU2010237120B8 (en) * | 2009-04-14 | 2015-11-26 | Laboratoire Hra-Pharma | Method for on-demand contraception |
PT2714712T (pt) | 2011-06-01 | 2016-11-08 | Estetra Sprl | Processo para a produção de intermediários de estetrol |
WO2012164096A1 (en) | 2011-06-01 | 2012-12-06 | Estetra S.A. | Process for the production of estetrol intermediates |
EP2383279A1 (en) | 2011-07-19 | 2011-11-02 | Pantarhei Bioscience B.V. | Process for the preparation of estetrol |
JP5928159B2 (ja) * | 2012-05-28 | 2016-06-01 | ニプロ株式会社 | 医薬組成物 |
FR2997627B1 (fr) | 2012-11-08 | 2015-01-16 | Hra Pharma Lab | Produit de co-micronisation comprenant de l'ulipristal acetate |
MA39105B1 (fr) * | 2013-12-12 | 2018-05-31 | Donesta Bioscience B V | Unité de dosage solide se désintégrant par voie orale contenant un constituant estétrol |
CN103877048A (zh) * | 2014-03-26 | 2014-06-25 | 邵娜 | 一种黄体酮口腔崩解片及其制备方法 |
WO2015160595A1 (en) * | 2014-04-14 | 2015-10-22 | Abbott Molecular, Inc. | Medium used for blood sample collection and transport |
MX2017016276A (es) | 2015-06-18 | 2018-06-19 | Mithra Pharmaceuticals S A | Unidad de dosificacion orodispersable que contiene un componente estetrol. |
MA44205B1 (fr) | 2015-06-18 | 2021-04-30 | Estetra Sprl | Comprimé orodispersible comprenant estetrol |
TN2017000497A1 (en) | 2015-06-18 | 2019-04-12 | Mithra Pharmaceuticals S A | Orodispersible dosage unit containing an estetrol component |
LT3310346T (lt) | 2015-06-18 | 2021-06-10 | Estetra Sprl | Burnoje disperguojama tabletė, turinti estetrolio |
WO2018010543A1 (zh) * | 2016-07-11 | 2018-01-18 | 武汉朗来科技发展有限公司 | 一种用于口服固体制剂的复合崩解剂体系及含有该复合崩解剂体系的口服固体制剂 |
KR20220144885A (ko) | 2016-08-05 | 2022-10-27 | 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 | 월경통 및 생리통의 관리방법 |
TWI801561B (zh) | 2018-04-19 | 2023-05-11 | 比利時商依思特拉私人有限責任公司 | 化合物及其用於緩解絕經相關症狀的用途 |
JOP20200260A1 (ar) | 2018-04-19 | 2019-10-19 | Estetra Sprl | مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث |
CN109276550B (zh) * | 2018-11-27 | 2021-01-12 | 西安圣雪沙药物开发有限公司 | 一种左炔诺孕酮片及其制备方法 |
CN110917154A (zh) * | 2019-12-12 | 2020-03-27 | 上海信谊天平药业有限公司 | 一种左炔诺孕酮片的制备方法 |
WO2022225986A1 (en) * | 2021-04-19 | 2022-10-27 | Archer David Fitzgerald | On demand female contraceptive |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE61236B1 (en) * | 1986-07-15 | 1994-10-19 | American Home Prod | Combination dosage form for pre-menopausal women |
US5633011A (en) * | 1994-08-04 | 1997-05-27 | Alza Corporation | Progesterone replacement therapy |
GB9603699D0 (en) * | 1996-02-21 | 1996-04-17 | Boots Co Plc | Therapeutic composition |
EP0904084A4 (en) * | 1996-05-16 | 2001-02-07 | Gynetics Inc | EMERGENCY CONCEPT PREVENTION KIT |
JPH1171268A (ja) * | 1997-08-28 | 1999-03-16 | Kayaku:Kk | 性ホルモン含有錠剤 |
FR2772617B1 (fr) * | 1997-12-19 | 2001-03-09 | Besins Iscovesco Lab | Comprime de progesterone et son procede de preparation |
US6368625B1 (en) * | 1998-08-12 | 2002-04-09 | Cima Labs Inc. | Orally disintegrable tablet forming a viscous slurry |
WO2000054752A1 (fr) * | 1999-03-15 | 2000-09-21 | Kaken Pharmaceutical Co., Ltd. | Comprimes a delitement rapide et procede de fabrication |
US6667050B1 (en) * | 1999-04-06 | 2003-12-23 | Galen (Chemicals) Limited | Chewable oral contraceptive |
US6316029B1 (en) * | 2000-05-18 | 2001-11-13 | Flak Pharma International, Ltd. | Rapidly disintegrating solid oral dosage form |
WO2002058696A2 (en) * | 2001-01-26 | 2002-08-01 | Schering Corporation | The use of substituted azetidinone compounds for the treatment of sitosterolemia |
HU227198B1 (en) * | 2001-11-27 | 2010-10-28 | Richter Gedeon Nyrt | Pharmaceutical composition for emergency contraception containing levonorgestrel |
US6962908B2 (en) * | 2001-12-21 | 2005-11-08 | Warner Chilcott Company Inc. | Oral pharmaceutical products containing 17 β-estradiol-3-lower alkanoate, method of administering the same and process of preparation |
EP1620075B1 (en) * | 2003-05-07 | 2020-06-24 | Samyang Biopharmaceuticals Corporation | Highly plastic granules for making fast melting tablets |
ES2688193T3 (es) * | 2003-10-15 | 2018-10-31 | Fuji Chemical Industry Co., Ltd. | Comprimido de disgregación rápida en la cavidad oral |
JP4519444B2 (ja) * | 2003-10-31 | 2010-08-04 | ライオン株式会社 | 口腔内崩壊錠 |
US8529939B2 (en) * | 2003-12-08 | 2013-09-10 | Gel-Del Technologies, Inc. | Mucoadhesive drug delivery devices and methods of making and using thereof |
EP1625849A1 (en) * | 2004-08-09 | 2006-02-15 | Liconsa, Liberacion Controlada de Sustancias Activas, S.A. | Pharmaceutical composition comprising drospirenone and ethynylestradiol |
CN1634077A (zh) * | 2004-11-18 | 2005-07-06 | 王立强 | 左炔诺孕酮口腔崩解片制剂及其制备方法 |
PL385455A1 (pl) * | 2005-04-22 | 2008-11-24 | Teva Pharmaceuticals Usa,Inc. | Doustna rozpadająca się farmaceutyczna tabletka preparatów olanzapiny |
WO2006128057A2 (en) * | 2005-05-26 | 2006-11-30 | Duramed Pharmaceuticals, Inc. | Oral dosage forms comprising progesterone and methods of making and using the same |
US7867515B2 (en) * | 2006-12-20 | 2011-01-11 | TEVA Woman's Health, Inc. | Orally disintegrating solid dosage forms comprising progestin and methods of making and use thereof |
BRPI0819571A2 (pt) * | 2007-12-20 | 2019-09-24 | Teva Womenss Health Inc | "método para contracepção de emergência, pacote farmacêutico para contracepção de emergência e composição farmacêutica" |
-
2007
- 2007-12-20 US US12/003,234 patent/US7867515B2/en not_active Expired - Fee Related
- 2007-12-20 AU AU2007338843A patent/AU2007338843B2/en not_active Ceased
- 2007-12-20 MX MX2009006823A patent/MX2009006823A/es active IP Right Grant
- 2007-12-20 WO PCT/US2007/025974 patent/WO2008079245A2/en active Application Filing
- 2007-12-20 CA CA002674776A patent/CA2674776A1/en not_active Abandoned
- 2007-12-20 EP EP07863134.8A patent/EP2124900B1/en active Active
- 2007-12-20 JP JP2009542901A patent/JP5649305B2/ja not_active Expired - Fee Related
- 2007-12-20 RU RU2009125972/15A patent/RU2465907C2/ru not_active IP Right Cessation
- 2007-12-20 ES ES07863134.8T patent/ES2531929T3/es active Active
- 2007-12-20 BR BRPI0719486-2A2A patent/BRPI0719486A2/pt not_active IP Right Cessation
-
2009
- 2009-06-21 IL IL199472A patent/IL199472A0/en unknown
-
2010
- 2010-12-02 US US12/958,975 patent/US8226980B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
RU2465907C2 (ru) | 2012-11-10 |
AU2007338843A1 (en) | 2008-07-03 |
US20110136771A1 (en) | 2011-06-09 |
US8226980B2 (en) | 2012-07-24 |
EP2124900B1 (en) | 2014-12-03 |
ES2531929T3 (es) | 2015-03-20 |
JP5649305B2 (ja) | 2015-01-07 |
US7867515B2 (en) | 2011-01-11 |
IL199472A0 (en) | 2010-03-28 |
MX2009006823A (es) | 2009-07-03 |
JP2010513514A (ja) | 2010-04-30 |
EP2124900A2 (en) | 2009-12-02 |
AU2007338843B2 (en) | 2013-05-09 |
RU2009125972A (ru) | 2011-01-27 |
WO2008079245A2 (en) | 2008-07-03 |
CA2674776A1 (en) | 2008-07-03 |
EP2124900A4 (en) | 2013-04-03 |
WO2008079245A3 (en) | 2008-12-04 |
US20080175906A1 (en) | 2008-07-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0719486A2 (pt) | "forma farmacêutica sólida oral desitegrante, não-efervescente, métodos para tratar uma mulher que necessite de um contraceptivo de emergência, pacote terapêutico para tratar uma mulher que necessite de contracepção de emergência e processo para a preparação de uma forma sólida de dosagem farmacêutica oral desintegrante, não-efervescente" | |
CY2016031I2 (el) | Τοπικη φαρμακοτεχνικη μορφη ιβερμεκτινης για την θεραπεια δερματολογικων καταστασεων | |
CL2007003609A1 (es) | Compuestos derivados de dihidropiridinas sustituidas; proceso de preparacion; compuestos intermediarios; composicion farmaceutica; proceso para producir la composicion farmaceutica; y uso en el tratamiento de una enfermedad mejorada con la inhibicion | |
BRPI0908292A2 (pt) | "métodos e composições para administração oral de exenatida" | |
BRPI0811317A2 (pt) | Combinação, embalagem farmcêutica, kit ou mbalagem par apaciente, agente auxiliar, compsoto, usos de um agente auxiliar e de um composto, e, processo para a produção de uma combinação | |
BRPI0919753B8 (pt) | forma polimórfica de palmitoiletanolamida, composição farmacêutica para uso humano ou veterinário, método para a micronização da palmitoiletanolamida e palmitoiletanolamida ultramicronizada | |
TR201900199T4 (tr) | Oksikodon ve nalokson içeren çabuk salımlı farmasötik bileşimler. | |
BRPI0722078A2 (pt) | Uso de composição de solução hipertônica em fabricação de medicamentos para promover a cicatrização de ferimento | |
CR10245A (es) | "nuevas combinaciones terapéuticas para el tratamiento de la depresión" | |
BR112015022465A2 (pt) | método para tratamento não-tóxico para síndrome de abstinência de drogas | |
BRPI0807285A2 (pt) | "composição, método para preparar composição farmacêutica, forma unitária de dosagem, método para admnistrar um agente biologicamente ativo a um animal necessitando o agente, método para aumentar a biodisponibilidade de um agente biologicamente ativo, método para preparar uma composição e composto" | |
CL2008000610A1 (es) | Composicion en forma de dosificacion transdermica o transmucosa que comprende una relacion en peso de buprenorfina a naloxona entre 2,1:1 y 8:1, util para el tratamiento del dolor. | |
BRPI0915829A2 (pt) | composições que têm o objetivo de promover o desenvolvimento e crescimento de uma microflora vaginal benéfica | |
CL2013001564A1 (es) | Metodo para tratar sobrepeso u obesidad que comprende administrar naltrexona y bupropion; metodo para incrementar la biodisponibilidad de naltrexona y bupropion en una terapia combinada; uso de naltrexona y bupropion para tratar sobrepeso u obesisdad e incrementar la biodisponibilidad de estos farmacos; composicion farmaceutica. | |
ZA200805761B (en) | Pharmaceutical composition for the treatment of nail disease | |
BRPI0818267A2 (pt) | Novos derivados de 1,3-dihidro-5-isobenzofuranocarbonitrila e composição farmacêutica dos mesmos para o tratamento de ejaculação precoce | |
BRPI0819571A2 (pt) | "método para contracepção de emergência, pacote farmacêutico para contracepção de emergência e composição farmacêutica" | |
GT200800235A (es) | Formulacion de medicamento liquida | |
EP2257263A4 (en) | TOPICAL FORMULATIONS FOR THE PREVENTION OF SEXUALLY TRANSMITABLE DISEASES AND METHOD FOR THE PRODUCTION THEREOF | |
CY1111361T1 (el) | Νεα προσδεματα συναγωνιστες των υποδοχεων rar, χρηση στην ανθρωπινη ιατρικη καθως και στην κοσμετολογια | |
CL2008002465A1 (es) | Composición farmacéutica anhidra tópica, que comprende derivados de niacina y un portador aceptable, su aplicacón permite un bienestar sexual mejorado. | |
BRPI0906045A2 (pt) | "composição farmacêutica para administração nasal" | |
PA8800601A1 (es) | Productos quimioterapeuticos cristalinos | |
ECSP066836A (es) | Piperazinas derivadas de úrea para el tratamiento de la endometrosis | |
BRPI0908024A2 (pt) | uso de s-adenosilmetionina (sam) e superóxido de dismutase (sod) para preparação de medicamentos para o tratamento de doença de alzheimer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 9A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] | ||
B25E | Requested change of name of applicant rejected |
Owner name: DURAMED PHARMACEUTICALS, INC (US) |